Literature DB >> 18040859

CD200-CD200R regulation of microglia activation in the pathogenesis of Parkinson's disease.

Xi-Jin Wang1, Min Ye, Yu-Hong Zhang, Sheng-Di Chen.   

Abstract

The role of CD200-CD200R signaling in immune regulation of the central nervous system has become a popular field of research in recent years. Many studies have shown that there is a close correlation between CD200-CD200R, microglia activation, and Parkinson's disease (PD). This review discusses the above relationship, highlighting (1) the gene mapping and molecular structure of CD200 and CD200R, (2) the distribution and expression of CD200 and CD200R in the nervous system, (3) the effect of CD200-CD200R signaling on microglia activation, and (4) the role of microglia activation in the pathogenesis and progression of PD. Finally, we discuss the status of current studies on the regulation of microglia activation in PD and strongly suggest that it is very promising to regulate microglia activation in PD via targeting CD200-CD200R signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18040859     DOI: 10.1007/s11481-007-9075-1

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  60 in total

1.  Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia.

Authors:  W G Kim; R P Mohney; B Wilson; G H Jeohn; B Liu; J S Hong
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

2.  Downregulation of transforming growth factor-beta2 facilitates inflammation in the central nervous system by reciprocal astrocyte/microglia interactions.

Authors:  Ines Siglienti; Andrew Chan; Christoph Kleinschnitz; Sebastian Jander; Klaus V Toyka; Ralf Gold; Guido Stoll
Journal:  J Neuropathol Exp Neurol       Date:  2007-01       Impact factor: 3.685

3.  Regulation of myeloid cell function through the CD200 receptor.

Authors:  Maria C Jenmalm; Holly Cherwinski; Edward P Bowman; Joseph H Phillips; Jonathon D Sedgwick
Journal:  J Immunol       Date:  2006-01-01       Impact factor: 5.422

Review 4.  Microglial cells in neurodegenerative disorders.

Authors:  Marcin Wojtera; Beata Sikorska; Tomasz Sobow; Paweł P Liberski
Journal:  Folia Neuropathol       Date:  2005       Impact factor: 2.038

5.  Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum.

Authors:  Y He; S Appel; W Le
Journal:  Brain Res       Date:  2001-08-03       Impact factor: 3.252

6.  Localisation of the MRC OX-2 glycoprotein on the surfaces of neurones.

Authors:  M Webb; A N Barclay
Journal:  J Neurochem       Date:  1984-10       Impact factor: 5.372

7.  Different reticular elements in rat lymphoid tissue identified by localization of Ia, Thy-1 and MRC OX 2 antigens.

Authors:  A N Barclay
Journal:  Immunology       Date:  1981-12       Impact factor: 7.397

8.  The unusual distribution of the neuronal/lymphoid cell surface CD200 (OX2) glycoprotein is conserved in humans.

Authors:  G J Wright; M Jones; M J Puklavec; M H Brown; A N Barclay
Journal:  Immunology       Date:  2001-02       Impact factor: 7.397

9.  Regulation of microglial cell responses in murine Toxoplasma encephalitis by CD200/CD200 receptor interaction.

Authors:  Martina Deckert; Jonathon D Sedgwick; Elena Fischer; Dirk Schlüter
Journal:  Acta Neuropathol       Date:  2006-04-28       Impact factor: 17.088

10.  (-)-Epigallocatechin gallate inhibits lipopolysaccharide-induced microglial activation and protects against inflammation-mediated dopaminergic neuronal injury.

Authors:  Rui Li; Yuan-Gui Huang; Du Fang; Wei-Dong Le
Journal:  J Neurosci Res       Date:  2004-12-01       Impact factor: 4.164

View more
  25 in total

1.  Neuroimmune pharmacology expanding in Asia Pacific rim.

Authors:  Jialin C Zheng; Sheng-Di Chen
Journal:  J Neuroimmune Pharmacol       Date:  2007-07-24       Impact factor: 4.147

Review 2.  Imaging microglial activation during neuroinflammation and Alzheimer's disease.

Authors:  Sriram Venneti; Clayton A Wiley; Julia Kofler
Journal:  J Neuroimmune Pharmacol       Date:  2008-12-04       Impact factor: 4.147

Review 3.  The impact of neuroimmune changes on development of amyloid pathology; relevance to Alzheimer's disease.

Authors:  Marina A Lynch
Journal:  Immunology       Date:  2014-03       Impact factor: 7.397

Review 4.  T cell-microglial dialogue in Parkinson's disease and amyotrophic lateral sclerosis: are we listening?

Authors:  Stanley H Appel; David R Beers; Jenny S Henkel
Journal:  Trends Immunol       Date:  2009-10-31       Impact factor: 16.687

5.  RING finger protein 11 (RNF11) modulates susceptibility to 6-OHDA-induced nigral degeneration and behavioral deficits through NF-κB signaling in dopaminergic cells.

Authors:  Elaine L Pranski; Nirjari V Dalal; Carson Van Sanford; Jeremy H Herskowitz; Marla Gearing; Carlos Lazo; Gary W Miller; James J Lah; Allan I Levey; Ranjita S Betarbet
Journal:  Neurobiol Dis       Date:  2013-01-11       Impact factor: 5.996

Review 6.  Role of Microglia in Neurological Disorders and Their Potentials as a Therapeutic Target.

Authors:  Li Du; Ying Zhang; Yang Chen; Jie Zhu; Yi Yang; Hong-Liang Zhang
Journal:  Mol Neurobiol       Date:  2016-11-09       Impact factor: 5.590

7.  Naloxone ameliorates retinal lesions in Ccl2/Cx3cr1 double-deficient mice via modulation of microglia.

Authors:  Defen Shen; Xiaoguang Cao; Lian Zhao; Jingsheng Tuo; Wai T Wong; Chi-Chao Chan
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-05-02       Impact factor: 4.799

8.  Altered regulation of CD200 receptor in monocyte-derived macrophages from individuals with Parkinson's disease.

Authors:  Xiao-Guang Luo; Ji-Juan Zhang; Chao-Dong Zhang; Rong Liu; Lan Zheng; Xi-Jin Wang; Sheng-Di Chen; Jian-Qing Ding
Journal:  Neurochem Res       Date:  2010-04       Impact factor: 3.996

9.  Dok2 mediates the CD200Fc attenuation of Aβ-induced changes in glia.

Authors:  Anthony Lyons; Eric J Downer; Derek A Costello; Niamh Murphy; Marina A Lynch
Journal:  J Neuroinflammation       Date:  2012-05-29       Impact factor: 8.322

10.  1α,25-dihydroxyvitamin D3 promotes CD200 expression by human peripheral and airway-resident T cells.

Authors:  Sarah Dimeloe; David F Richards; Zoe L Urry; Atul Gupta; Victoria Stratigou; Sophie Farooque; Sejal Saglani; Andrew Bush; Catherine M Hawrylowicz
Journal:  Thorax       Date:  2012-02-14       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.